Navigation Links
Bio/Pharmaceutical Contract Manufacturing - Industry Analysis of Dose Manufacturing by the Numbers: Composition, Size, Market Shares, Profitability and Outlook

Fairfax, VA (PRWEB) September 04, 2013

In their latest Special Report, PharmSouce experts present an important expert analysis of the bio/pharmaceutical contract dose manufacturing industry. Founded on the industry’s most comprehensive database of the dose CMO industry (PharmSource’s STRATEGIC ADVANTAGE Database of Contract Service Providers), this analysis is driven by the organization's proprietary model of the dose manufacturing industry which is continuously updated and refined. The model and assumptions are fully explained so readers can understand how the analysis and conclusions were established.

The report characterizes the bio/pharmaceutical contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size, market shares of the top CMOs and profitability, and provides PharmSource’s expert outlook for the industry.

For purposes of this report, the contract dose manufacturing universe includes companies that actively promote themselves as contract manufacturers (CMOs) and produce client formulations for pharmaceuticals supplied to the highly regulated markets in North America, Europe and Japan. The contract dose manufacturing universe is defined by 195 companies headquartered primarily in North America, Europe, Japan and India.

This 27-page report includes an Executive Summary, and chapters on Industry Composition and Size, CMO Market Shares, and CMO Profitability, and concludes with a chapter on What it Means, which further assesses the implications of the conclusions for the dose CMO industry. In addition, appendices on methodology and a listing of companies included in the CMO universe as defined are included.

Who should read and study this report? The expertise and skilled analysis in this report gives important insight not available in any other source. This report is required reading for each of the following professionals: 1) CMO executives and strategic decision-makers, who will find it to be an indispensable resource for understanding the industry and a critical input for strategic planning efforts; 2) Sourcing and procurement executives in bio/pharmaceutical companies who seek insights for supplier selection and management, who will find the report a critical resource for understanding crucial components of the supply base; 3) Private equity investors, who will gain an important deeper understanding of the market and indispensable insight for identifying potential investment targets; and 4) Anyone needing a deeper understanding of the bio/pharmaceutical contract dose manufacturing market.

For a limited time, PharmSource is offering a complimentary test-drive and a 15% annual discount on PharmSource STRATEGIC ADVANTAGE online service to qualified companies (new subscribers only). For more information, contact PharmSource's Customer Service Department at +1-703-383-4903,ext. 101 / info(at)pharmsource(dot)com.

About PharmSource

PharmSource Information Services, Inc. is a respected provider of business intelligence on contract drug development and manufacture. PharmSource assists Biotechnology and Pharmaceutical companies in implementing and managing sourcing strategies and programs. They also provide business development products and services to companies that serve the biotechnology and pharmaceutical industries. Since 1996, organizations involved in contract Pharma services have continuously relied on PharmSource publications, databases, surveys and consulting services to provide timely, accurate information and analysis. Visit PharmSource on the web at or contact them at +1-703-383-4903 (USA, eastern time-zone).

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
2. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at
3. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
4. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
5. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
6. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
7. ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes
8. Non-Intrusive Rust Remover Gives Out New Set of Samples to Rust Contractors, My Cleaning Products Says the Spray Cuts $1,000s of Rust Removal Expense
9. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
10. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
11. Sterilization Market (Medical Devices, Pharmaceutical, Healthcare, Food Applications), Equipments & Contract Services - Global Forecast To 2017
Post Your Comments:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):